Abstract
Serum prolactin concentrations were measured by radioimmunoassays in 98 patients with established carcinoma of breast, 12 patients with cystic mastitis and 10 patients with gynaecomastia and compared with that of age matched normal control women. The serum prolactin levels in the patients with breast cancer, gynaecomastia or cystic mastitis were observed to be similar to that in normal women. It was interesting to note that the levels of prolactin in the luteal phase of the cycle were higher than that in the early follicular phase in normal women.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Sheth, N., Ranadive, K., Suraiya, J. et al. Circulating levels of prolactin in human breast cancer. Br J Cancer 32, 160–167 (1975). https://doi.org/10.1038/bjc.1975.145
Issue Date:
DOI: https://doi.org/10.1038/bjc.1975.145
This article is cited by
-
Prolactin and Breast Cancer Etiology: An Epidemiologic Perspective
Journal of Mammary Gland Biology and Neoplasia (2008)
-
Circulating peptide and steroid hormone levels in patients with breast cancer
Indian Journal of Clinical Biochemistry (1994)
-
Epidemiology and endocrinology of benign breast disease
Breast Cancer Research and Treatment (1985)
